On each episode of "TD Cowen Insights", members of our firm host leading thinkers to share insights and ideas shaping the world economy. Join us, as we converse with the top minds who are influencing our global sectors. Disclosures: https://go.td.com/PodcastDisclosure
Listen to episodes
60 recent
August 28, 202619 min
Moose Knuckles' Bold Vision For Luxury Outerwear
Recorded on 07/15/26 Authentic Canadian Craftsmanship & Rebellious Relevance. We hosted CEO Ellen Kinney to discuss the brand's global growth opportunity as it balances outerwear leadership and luxury craftsmanship with broader lifestyle ambitions. Key themes included selective distribution, co-creation over celebrity, disciplined inventory management, and maintaining brand authenticity while scaling internationally. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
August 20, 202633 min
Clinical Science Meets Longevity With IM8 Co-Founder & CEO
Recorded on 08/04/26 David Beckham's Clinically Validated, NSF-Certified Wellness: Prenetics. We host Danny Yeung, Co-Founder & CEO of IM8 & Prenetics, to discuss building one of consumer health's fastest-growing wellness brands with Co-Founder David Beckham. We explore longevity innovation, clinical validation, DTC scaling, subscription economics, global expansion, & the future of science-backed preventive health. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
August 11, 202623 min
Navigating The FDA Playbook For Psychedelic Therapies
Recorded on 07/17/26 TD Cowen senior analyst Ritu Baral hosts Michael McCaughan, founder of Prevision Policy, a leading provider of regulatory and reimbursement policy analysis for the biopharma industry. Discussion focused on the evolving regulatory landscape for psychedelic treatments. McCaughan views FDA as already receptive to psychedelics from the bottom up, with the recent executive order on accelerating psychedelic development and approval adding clear new top-down support. He does not believe the updated 2026 FDA industry guidance meaningfully changes the approvability bar for psychedelic sponsors, especially those with NDAs in progress. He views the recommendation for 12-month blinded follow-up as unlikely to be an approvability issue for these near term, and even Ph3 programs, although it could influence label language, durability claims, and claims on repeat dosing. On safety, he expects FDA to focus on if benefit outweighs key risks, including suicidality, abuse potential, and class-specific concerns such as cardiovascular or valvulopathy signals. He also expects a REMS framework anchored by in-office administration and misuse prevention, likely informed by Spravato but tailored to the psychedelic treatment model. Importantly, he believes FDA and DEA are likely to work together to minimize the gap between approval and rescheduling, though process and bureaucracy remain key timing variables. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
August 6, 202622 min
What's Happening With Consumer Finance
Recorded on 08/06/26 TD Cowen financial policy analyst Jaret Seiberg hosts TD Cowen's Two Cents Podcast, which this month features a conversation with Moshe Orenbuch, an equity analyst at TD Cowen who focuses on the consumer finance sector. We talk about credit growth, credit quality, and policy challenges. Also, TD Cowen's Scott Smith gives an assessment of bank earnings season. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
July 30, 202635 min
How Faire's Digital Approach To Wholesale Empowers Retail
Recorded on 07/15/26 Learn About Global Wholesale Platform Powering Independent Retail. We host Jeff Kolovson, co-founder & COO of Faire, a wholesale technology platform that helps retailers discover brands and products to stock. We discuss how the company is transforming wholesale for independent retailers and brands, and cover topics including AI-powered discovery, network effects, and the future of trade shows. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
July 27, 202627 min
Meeting The Moment With Tools Of Tomorrow With Twist Bioscience's Patrick Finn
Recorded on 07/15/26 In this episode, TD Cowen's health care analyst Brendan Smith hosts Patrick Finn, President and COO of Twist Bioscience, to explore how companies like Twist are capitalizing on the evolving drug development landscape and what impact biopharma's ramping use of AI is having on life science tools providers across the industry. We discuss how big tech companies are expanding into the life sciences, whether dry-lab-first innovators could be the drug developers of the future, and how we should think about what it takes to "win" in the space moving forward. We also aim to unpack whether wet lab validation will remain an essential part of drug development for the foreseeable future and how durable this wave of data demand could be over the coming years. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
July 21, 202639 min
Inside A Commercial Interventional Psychiatry Clinic: Preparing For The Next Wave Of Psychedelic Treatments
Recorded on 07/09/26 Senior analyst Ritu Baral hosts Dr. Tobias ("Toby") Marton, CMO of Mindful Health Solutions, to discuss how a large commercial interventional psychiatry network operates and how clinics may adapt as psilocybin-based therapies such as COMP360 move closer to potential FDA approval. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
July 20, 202653 min
USA-IRI Ceasefire Over & FY27 Budget Outlook Murky Into Fall
Recorded on 07/17/26 In this episode, Roman Schweizer, TD Cowen’s WRG geopolitics & defense analyst, is joined by an all-star reporter roundtable to discuss the resumed war between the USA and IRI, the complicated picture of defense spending heading into FY27, and a preview of the Farnborough International Air Show. The budget outlook is muddled along multiple tracks (the base budget, a third or fourth reconciliation package, and a DoW supplemental request). And Congress needs to get a continuing resolution in place before October 1 or there could be a shutdown. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
July 15, 202618 min
Geneoscopy CEO Andrew Barnell On Transforming GI Health: RNA-Based Diagnostics, CRC Screening Opportunity, & Platform Potential Ahead
Recorded on 07/09/26 TD Cowen Life Science & Diagnostic Tools analyst Dan Brennan speaks with Geneoscopy CEO Andrew Barnell post TD Cowen's 5th Annual Tools/Dx Revolution Conference to discuss GI healthcare and the future of GI cancer diagnostics, and Geneoscopy's innovations, partnerships, and growth pillars ahead. Geneoscopy is leveraging its proprietary RNA platform to advance colorectal cancer (CRC) screening through ColoSense, a non-invasive FDA-approved and Medicare-covered stool test. Barnell discusses the origins of the company, the scientific rationale behind their platform, recent commercialization milestones including their partnership with LabCorp, and the company's vision to expand beyond CRC into broader GI indications such as inflammatory bowel disease. Barnell also shares perspectives on competitive differentiation, CRC screening adoption drivers, the role of AI in diagnostics, and Geneoscopy's long-term mission to transform the diagnosis, monitoring and management of GI diseases. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
July 14, 202628 min
Kevin Warsh And The Future Direction For Rates
Recorded on 07/14/26 TD Cowen financial policy analyst Jaret Seiberg hosts TD Cowen's Two Cents Podcast, which this month features a conversation with Gennadiy Goldberg, the head of rates strategy at TD Securities. We look at Kevin Warsh's first few weeks on the job as Federal Reserve chair and assess what it means for interest rates going forward. In addition, TD Cowen specialty salesperson Scott Smith gives an assessment of bank earnings season. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Is this your show?
Claim this listing to keep it up to date, reach guests who want to pitch you, and manage bookings with Guestify.
